Document Detail


Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine.
MedLine Citation:
PMID:  18989881     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Juvenile xanthogranulomatosis (JXG) is an uncommon histiocytic disease that is usually limited to the skin. Here we describe an infant with systemic JXG including a central nervous system (CNS) lesion. He was initially treated with prednisolone and vinblastine but developed an idiosyncratic reaction to prednisolone that was discontinued. The lesion then failed to respond to vinblastine monotherapy. Treatment with cladribine (2-chlorodeoxyadenosine) was subsequently successful with radiological resolution of the CNS lesion.
Authors:
Barathi Rajendra; Alison Duncan; Richard Parslew; Barry L Pizer
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric blood & cancer     Volume:  52     ISSN:  1545-5017     ISO Abbreviation:  Pediatr Blood Cancer     Publication Date:  2009 Mar 
Date Detail:
Created Date:  2009-01-15     Completed Date:  2009-01-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101186624     Medline TA:  Pediatr Blood Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  413-5     Citation Subset:  IM    
Affiliation:
Department of Oncology, RLC NHS Trust, Alder Hey, Liverpool, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Central Nervous System Diseases / drug therapy*,  radiography
Cladribine / therapeutic use*
Follow-Up Studies
Humans
Infant
Male
Tomography, X-Ray Computed
Xanthogranuloma, Juvenile / drug therapy*,  radiography
Chemical
Reg. No./Substance:
4291-63-8/Cladribine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals.
Next Document:  NOLA1 gene mutations in acquired aplastic anemia.